Bilimsel çalışmalar

Dr. Engin Erdemoğlu

12 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön
  1. Chemotherapy Response Score and Survival Outcomes After Neoadjuvant Chemotherapy in High-Grade Serous Tubo-Ovarian Carcinoma: A Multicenter Retrospective Study

    Medicina, 2026

    DOI 10.3390/medicina62091688 PMID 42796295 Açık erişimli tam metinKaynak: OpenAlex

  2. Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33060365 PMID 42346265 Açık erişimli tam metinKaynak: OpenAlex

  3. Evaluation of Olaparib Efficacy Following CDK4/6 Inhibitor Therapy in BRCA-Mutated, Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Turkish Oncology Group (TOG) Study

    Targeted Oncology, 2026

    DOI 10.1007/s11523-026-01261-w PMID 42907609 Kaynak: OpenAlex

  4. CT-defined sarcopenia and outcomes in HR+/HER2− metastatic breast cancer treated with CDK4/6 inhibitors

    Frontiers in Medicine, 2026

    DOI 10.3389/fmed.2026.1943515 Açık erişimli tam metinKaynak: OpenAlex

  5. Management of hepatotoxicity associated with CDK4/6 inhibitors and rechallenge strategies in metastatic hormone-positive, HER2-negative breast cancer

    Journal of Cancer Research and Clinical Oncology, 2025

    DOI 10.1007/s00432-025-06336-1 PMID 41014426 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  6. THE ROLE OF IMMUNOTHERAPY IN THE TREATMENT OF COLORECTAL CANCER

    Turkiye Klinikleri eBooks, 2025

    DOI 10.5336/978-625-395-770-4_p131 Kaynak: OpenAlex

  7. Safety and survival in adult women with platinum sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study.

    Journal of Clinical Oncology, 2023

    DOI 10.1200/jco.2023.41.16_suppl.e17509 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  8. Psychological state and predictors of psychiatric morbidity in COVID-19 patients six weeks after discharge

    Archives of Psychiatric Nursing, 2023

    DOI 10.1016/j.apnu.2023.07.003 PMID 37813498 Açık erişimli tam metinKaynak: ORCID

  9. Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study

    Future Oncology, 2022

    DOI 10.2217/fon-2021-1248 PMID 35081732 27 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  10. Frequency of coagulation test results being in the therapeutic range in patients using warfarin treatment,Varfarin tedavisi alan hastalarda koagülasyon testlerinin terapötik aralıkta olma oranı

    Medeniyet Medical Journal, 2015

    DOI 10.5222/mmj.2015.105 Açık erişimli tam metinKaynak: ORCID

  11. A case of classic polyarteritis nodosa resembling lupus nephritis

    Turkish Nephrology Dialysis and Transplantation Journal, 2014

    DOI 10.5262/tndt.2014.1002.19 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  12. Leptin parameters are associated with inflammation and both anthropometric and serum markers of protein-energy wasting in hemodialysis patients

    Turkish Nephrology Dialysis and Transplantation Journal, 2014

    DOI 10.5262/tndt.2014.1002.02 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID